Vertaile menetelmiä

	qSOFA-pistemäärä	CURB-65 -keuhkokuumeen vaikeusasteen pisteytys	Muutettu varhaisen varoituksen pistejärjestelmä
Tieteenala	Kliininen arviointi	Kliininen arviointi	Kliininen arviointi
Menetelmäperhe	Process / pipeline	Process / pipeline	Process / pipeline
Syntyvuosi	2016	2003	2001
Kehittäjä	Sepsis-3 Taskforce	W. Staniford Lim, et al.	Christian P. Subbe, et al.
Tyyppi	Rapid sepsis screening	Community-acquired pneumonia severity assessment	Hospital ward deterioration warning system
Alkuperäislähde	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.	Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.	Subbe, C. P., Kruger, M., Rutherford, P., & Gemmel, L. (2001). Validation of a modified Early Warning Score in medical admissions. QJM: An International Journal of Medicine, 94(10), 521-526.
Rinnakkaisnimet	Quick SOFA, qSOFA	CURB-65, Pneumonia severity	MEWS, Early warning score
Liittyvät	3	3	3
Tiivistelmä	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.	CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.	The Modified Early Warning Score (MEWS), introduced by Subbe et al. in 2001, is a 14-point alert system designed for rapid detection of clinical deterioration in hospitalized patients. It combines six vital sign and laboratory parameters to identify patients at high risk of rapid decline, enabling early intervention before critical events occur.